BELLICUM PHARMACEUTICALS INC's ticker is BLCM and the CUSIP is 079481107. A total of 91 filers reported holding BELLICUM PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 1.40 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $54,000 | -62.5% | 31,837 | -25.3% | 0.00% | -100.0% |
| Q1 2019 | $144,000 | -47.6% | 42,633 | -54.7% | 0.00% | -50.0% |
| Q4 2018 | $275,000 | -4.5% | 94,141 | +101.2% | 0.00% | 0.0% |
| Q3 2018 | $288,000 | +82.3% | 46,799 | +117.9% | 0.00% | +100.0% |
| Q2 2018 | $158,000 | +95.1% | 21,474 | +74.2% | 0.00% | – |
| Q1 2018 | $81,000 | -10.0% | 12,326 | +15.0% | 0.00% | – |
| Q4 2017 | $90,000 | -71.8% | 10,717 | -28.6% | 0.00% | -100.0% |
| Q2 2015 | $319,000 | – | 15,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 1,051,441 | $3,070,000 | 0.79% |
| X-Square Capital, LLC | 109,832 | $321,000 | 0.25% |
| KNOTT DAVID M | 111,427 | $325,000 | 0.15% |
| ARK Investment Management | 1,033,491 | $3,018,000 | 0.12% |
| Baker Brothers Advisors | 2,677,818 | $7,819,000 | 0.06% |
| HARVEY CAPITAL MANAGEMENT INC | 31,200 | $91,000 | 0.05% |
| DAFNA Capital Management LLC | 30,000 | $88,000 | 0.04% |
| WASATCH ADVISORS LP | 953,368 | $2,784,000 | 0.04% |
| FRANKLIN STREET ADVISORS INC /NC | 51,415 | $150,000 | 0.02% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,000,000 | $2,920,000 | 0.02% |